Endothelial Cell Adhesion Molecules- (un)Attainable Targets for Nanomedicines
Endothelial cell adhesion molecules have long been proposed as promising targets in many pathologies. Despite promising preclinical data, several efforts to develop small molecule inhibitors or monoclonal antibodies (mAbs) against cell adhesion molecules (CAMs) ended in clinical-stage failure. In pa...
Principais autores: | , , |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Frontiers Media S.A.
2022-04-01
|
coleção: | Frontiers in Medical Technology |
Assuntos: | |
Acesso em linha: | https://www.frontiersin.org/articles/10.3389/fmedt.2022.846065/full |